nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotetan—ALB—lung cancer	0.482	1	CbGaD
Cefotetan—ALB—Gefitinib—lung cancer	0.147	0.415	CbGbCtD
Cefotetan—ALB—Erlotinib—lung cancer	0.0871	0.246	CbGbCtD
Cefotetan—ALB—Irinotecan—lung cancer	0.0786	0.222	CbGbCtD
Cefotetan—ALB—Methotrexate—lung cancer	0.0416	0.117	CbGbCtD
Cefotetan—Neutropenia—Irinotecan—lung cancer	0.000528	0.00327	CcSEcCtD
Cefotetan—Vomiting—Crizotinib—lung cancer	0.000528	0.00327	CcSEcCtD
Cefotetan—Phlebitis—Docetaxel—lung cancer	0.000524	0.00325	CcSEcCtD
Cefotetan—Rash—Crizotinib—lung cancer	0.000523	0.00324	CcSEcCtD
Cefotetan—Dermatitis—Crizotinib—lung cancer	0.000523	0.00324	CcSEcCtD
Cefotetan—Pancytopenia—Gemcitabine—lung cancer	0.000523	0.00323	CcSEcCtD
Cefotetan—Diarrhoea—Pemetrexed—lung cancer	0.000519	0.00321	CcSEcCtD
Cefotetan—Diarrhoea—Gefitinib—lung cancer	0.000516	0.00319	CcSEcCtD
Cefotetan—Neutropenia—Gemcitabine—lung cancer	0.000515	0.00318	CcSEcCtD
Cefotetan—Leukopenia—Vinblastine—lung cancer	0.000514	0.00318	CcSEcCtD
Cefotetan—Gastrointestinal pain—Teniposide—lung cancer	0.000502	0.00311	CcSEcCtD
Cefotetan—Leukopenia—Topotecan—lung cancer	0.000499	0.00309	CcSEcCtD
Cefotetan—Convulsion—Vinblastine—lung cancer	0.000498	0.00308	CcSEcCtD
Cefotetan—Nausea—Crizotinib—lung cancer	0.000493	0.00305	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Etoposide—lung cancer	0.00049	0.00303	CcSEcCtD
Cefotetan—Urticaria—Teniposide—lung cancer	0.000488	0.00302	CcSEcCtD
Cefotetan—Pancytopenia—Cisplatin—lung cancer	0.000487	0.00301	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Gemcitabine—lung cancer	0.000486	0.00301	CcSEcCtD
Cefotetan—Abdominal pain—Teniposide—lung cancer	0.000486	0.00301	CcSEcCtD
Cefotetan—Body temperature increased—Teniposide—lung cancer	0.000486	0.00301	CcSEcCtD
Cefotetan—Discomfort—Vinblastine—lung cancer	0.000483	0.00299	CcSEcCtD
Cefotetan—Vomiting—Pemetrexed—lung cancer	0.000482	0.00298	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Paclitaxel—lung cancer	0.00048	0.00297	CcSEcCtD
Cefotetan—Vomiting—Gefitinib—lung cancer	0.000479	0.00297	CcSEcCtD
Cefotetan—Rash—Pemetrexed—lung cancer	0.000478	0.00296	CcSEcCtD
Cefotetan—Dermatitis—Pemetrexed—lung cancer	0.000478	0.00296	CcSEcCtD
Cefotetan—Rash—Gefitinib—lung cancer	0.000475	0.00294	CcSEcCtD
Cefotetan—Dermatitis—Gefitinib—lung cancer	0.000475	0.00294	CcSEcCtD
Cefotetan—Discomfort—Topotecan—lung cancer	0.000469	0.0029	CcSEcCtD
Cefotetan—Thrombocytopenia—Vinblastine—lung cancer	0.000459	0.00284	CcSEcCtD
Cefotetan—Agranulocytosis—Gemcitabine—lung cancer	0.000458	0.00283	CcSEcCtD
Cefotetan—Anaphylactic shock—Topotecan—lung cancer	0.000455	0.00282	CcSEcCtD
Cefotetan—Haemoglobin—Irinotecan—lung cancer	0.000454	0.00281	CcSEcCtD
Cefotetan—Cefpiramide—ALB—lung cancer	0.000453	0.252	CrCbGaD
Cefotetan—Hypersensitivity—Teniposide—lung cancer	0.000453	0.0028	CcSEcCtD
Cefotetan—Haemorrhage—Irinotecan—lung cancer	0.000452	0.0028	CcSEcCtD
Cefotetan—Nausea—Pemetrexed—lung cancer	0.00045	0.00279	CcSEcCtD
Cefotetan—Vaginal inflammation—Methotrexate—lung cancer	0.000449	0.00278	CcSEcCtD
Cefotetan—Nausea—Gefitinib—lung cancer	0.000448	0.00277	CcSEcCtD
Cefotetan—Pancytopenia—Etoposide—lung cancer	0.000446	0.00276	CcSEcCtD
Cefotetan—Thrombocytopenia—Topotecan—lung cancer	0.000446	0.00276	CcSEcCtD
Cefotetan—Haemoglobin—Gemcitabine—lung cancer	0.000443	0.00274	CcSEcCtD
Cefotetan—Thrombocytopenia—Erlotinib—lung cancer	0.000441	0.00273	CcSEcCtD
Cefotetan—Haemorrhage—Gemcitabine—lung cancer	0.00044	0.00273	CcSEcCtD
Cefotetan—Neutropenia—Etoposide—lung cancer	0.000439	0.00272	CcSEcCtD
Cefotetan—Pancytopenia—Paclitaxel—lung cancer	0.000438	0.00271	CcSEcCtD
Cefotetan—Pruritus—Teniposide—lung cancer	0.000435	0.00269	CcSEcCtD
Cefotetan—Neutropenia—Paclitaxel—lung cancer	0.000431	0.00267	CcSEcCtD
Cefotetan—Leukopenia—Vinorelbine—lung cancer	0.000427	0.00264	CcSEcCtD
Cefotetan—Vaginal infection—Methotrexate—lung cancer	0.000424	0.00262	CcSEcCtD
Cefotetan—Aplastic anaemia—Methotrexate—lung cancer	0.000421	0.00261	CcSEcCtD
Cefotetan—Diarrhoea—Teniposide—lung cancer	0.00042	0.0026	CcSEcCtD
Cefotetan—Erythema multiforme—Gemcitabine—lung cancer	0.000416	0.00258	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Etoposide—lung cancer	0.000415	0.00257	CcSEcCtD
Cefotetan—Blood bilirubin increased—Doxorubicin—lung cancer	0.000411	0.00254	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Paclitaxel—lung cancer	0.000407	0.00252	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Docetaxel—lung cancer	0.000407	0.00252	CcSEcCtD
Cefotetan—Discomfort—Vinorelbine—lung cancer	0.000401	0.00248	CcSEcCtD
Cefotetan—Cefonicid—ALB—lung cancer	0.000394	0.219	CrCbGaD
Cefotetan—Agranulocytosis—Etoposide—lung cancer	0.000391	0.00242	CcSEcCtD
Cefotetan—Vomiting—Teniposide—lung cancer	0.000391	0.00242	CcSEcCtD
Cefotetan—Anaphylactic shock—Vinorelbine—lung cancer	0.00039	0.00241	CcSEcCtD
Cefotetan—Vaginal inflammation—Doxorubicin—lung cancer	0.000388	0.0024	CcSEcCtD
Cefotetan—Rash—Teniposide—lung cancer	0.000387	0.0024	CcSEcCtD
Cefotetan—Dermatitis—Teniposide—lung cancer	0.000387	0.00239	CcSEcCtD
Cefotetan—Gastrointestinal pain—Vinblastine—lung cancer	0.000383	0.00237	CcSEcCtD
Cefotetan—Thrombocytopenia—Vinorelbine—lung cancer	0.000381	0.00236	CcSEcCtD
Cefotetan—Colitis—Doxorubicin—lung cancer	0.000373	0.00231	CcSEcCtD
Cefotetan—Gastrointestinal pain—Topotecan—lung cancer	0.000372	0.0023	CcSEcCtD
Cefotetan—Pancytopenia—Docetaxel—lung cancer	0.000371	0.0023	CcSEcCtD
Cefotetan—Haemoglobin—Paclitaxel—lung cancer	0.000371	0.00229	CcSEcCtD
Cefotetan—Abdominal pain—Vinblastine—lung cancer	0.000371	0.00229	CcSEcCtD
Cefotetan—Haemorrhage—Paclitaxel—lung cancer	0.000369	0.00228	CcSEcCtD
Cefotetan—Gastrointestinal pain—Erlotinib—lung cancer	0.000368	0.00228	CcSEcCtD
Cefotetan—Vaginal infection—Doxorubicin—lung cancer	0.000367	0.00227	CcSEcCtD
Cefotetan—Neutropenia—Docetaxel—lung cancer	0.000365	0.00226	CcSEcCtD
Cefotetan—Nausea—Teniposide—lung cancer	0.000365	0.00226	CcSEcCtD
Cefotetan—Aplastic anaemia—Doxorubicin—lung cancer	0.000365	0.00226	CcSEcCtD
Cefotetan—Urticaria—Topotecan—lung cancer	0.000362	0.00224	CcSEcCtD
Cefotetan—Abdominal pain—Topotecan—lung cancer	0.00036	0.00223	CcSEcCtD
Cefotetan—Body temperature increased—Topotecan—lung cancer	0.00036	0.00223	CcSEcCtD
Cefotetan—Abdominal pain—Erlotinib—lung cancer	0.000356	0.0022	CcSEcCtD
Cefotetan—Body temperature increased—Erlotinib—lung cancer	0.000356	0.0022	CcSEcCtD
Cefotetan—Erythema multiforme—Etoposide—lung cancer	0.000356	0.0022	CcSEcCtD
Cefotetan—Leukopenia—Irinotecan—lung cancer	0.000352	0.00218	CcSEcCtD
Cefotetan—Erythema multiforme—Paclitaxel—lung cancer	0.000349	0.00216	CcSEcCtD
Cefotetan—Cefmetazole—ALB—lung cancer	0.000347	0.193	CrCbGaD
Cefotetan—Hypersensitivity—Vinblastine—lung cancer	0.000345	0.00214	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Docetaxel—lung cancer	0.000345	0.00214	CcSEcCtD
Cefotetan—Leukopenia—Gemcitabine—lung cancer	0.000343	0.00212	CcSEcCtD
Cefotetan—Hypersensitivity—Topotecan—lung cancer	0.000335	0.00208	CcSEcCtD
Cefotetan—Discomfort—Irinotecan—lung cancer	0.000331	0.00205	CcSEcCtD
Cefotetan—Phlebitis—Doxorubicin—lung cancer	0.000327	0.00203	CcSEcCtD
Cefotetan—Agranulocytosis—Docetaxel—lung cancer	0.000325	0.00201	CcSEcCtD
Cefotetan—Hepatic function abnormal—Doxorubicin—lung cancer	0.000323	0.002	CcSEcCtD
Cefotetan—Discomfort—Gemcitabine—lung cancer	0.000323	0.002	CcSEcCtD
Cefotetan—Pruritus—Topotecan—lung cancer	0.000322	0.00199	CcSEcCtD
Cefotetan—Anaphylactic shock—Irinotecan—lung cancer	0.000321	0.00199	CcSEcCtD
Cefotetan—Diarrhoea—Vinblastine—lung cancer	0.000321	0.00198	CcSEcCtD
Cefotetan—Leukopenia—Cisplatin—lung cancer	0.00032	0.00198	CcSEcCtD
Cefotetan—Pruritus—Erlotinib—lung cancer	0.000319	0.00197	CcSEcCtD
Cefotetan—Gastrointestinal pain—Vinorelbine—lung cancer	0.000319	0.00197	CcSEcCtD
Cefotetan—Thrombocytopenia—Irinotecan—lung cancer	0.000315	0.00195	CcSEcCtD
Cefotetan—Haemoglobin—Docetaxel—lung cancer	0.000314	0.00194	CcSEcCtD
Cefotetan—Anaphylactic shock—Gemcitabine—lung cancer	0.000313	0.00194	CcSEcCtD
Cefotetan—Haemorrhage—Docetaxel—lung cancer	0.000313	0.00193	CcSEcCtD
Cefotetan—Diarrhoea—Topotecan—lung cancer	0.000312	0.00193	CcSEcCtD
Cefotetan—Convulsion—Cisplatin—lung cancer	0.00031	0.00192	CcSEcCtD
Cefotetan—Urticaria—Vinorelbine—lung cancer	0.000309	0.00192	CcSEcCtD
Cefotetan—Diarrhoea—Erlotinib—lung cancer	0.000308	0.00191	CcSEcCtD
Cefotetan—Body temperature increased—Vinorelbine—lung cancer	0.000308	0.00191	CcSEcCtD
Cefotetan—Abdominal pain—Vinorelbine—lung cancer	0.000308	0.00191	CcSEcCtD
Cefotetan—Thrombocytopenia—Gemcitabine—lung cancer	0.000306	0.0019	CcSEcCtD
Cefotetan—Discomfort—Cisplatin—lung cancer	0.000301	0.00186	CcSEcCtD
Cefotetan—Vomiting—Vinblastine—lung cancer	0.000298	0.00184	CcSEcCtD
Cefotetan—Erythema multiforme—Docetaxel—lung cancer	0.000296	0.00183	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.000293	0.00181	CcSEcCtD
Cefotetan—Leukopenia—Etoposide—lung cancer	0.000293	0.00181	CcSEcCtD
Cefotetan—Anaphylactic shock—Cisplatin—lung cancer	0.000292	0.00181	CcSEcCtD
Cefotetan—Vomiting—Topotecan—lung cancer	0.00029	0.00179	CcSEcCtD
Cefotetan—Leukopenia—Paclitaxel—lung cancer	0.000287	0.00178	CcSEcCtD
Cefotetan—Rash—Topotecan—lung cancer	0.000287	0.00178	CcSEcCtD
Cefotetan—Hypersensitivity—Vinorelbine—lung cancer	0.000287	0.00178	CcSEcCtD
Cefotetan—Dermatitis—Topotecan—lung cancer	0.000287	0.00178	CcSEcCtD
Cefotetan—Vomiting—Erlotinib—lung cancer	0.000286	0.00177	CcSEcCtD
Cefotetan—Thrombocytopenia—Cisplatin—lung cancer	0.000286	0.00177	CcSEcCtD
Cefotetan—Rash—Erlotinib—lung cancer	0.000284	0.00176	CcSEcCtD
Cefotetan—Dermatitis—Erlotinib—lung cancer	0.000284	0.00176	CcSEcCtD
Cefotetan—Convulsion—Etoposide—lung cancer	0.000284	0.00176	CcSEcCtD
Cefotetan—Eosinophilia—Methotrexate—lung cancer	0.000279	0.00172	CcSEcCtD
Cefotetan—Nausea—Vinblastine—lung cancer	0.000278	0.00172	CcSEcCtD
Cefotetan—Convulsion—Paclitaxel—lung cancer	0.000278	0.00172	CcSEcCtD
Cefotetan—Pruritus—Vinorelbine—lung cancer	0.000276	0.00171	CcSEcCtD
Cefotetan—Discomfort—Etoposide—lung cancer	0.000275	0.0017	CcSEcCtD
Cefotetan—Nausea—Topotecan—lung cancer	0.00027	0.00167	CcSEcCtD
Cefotetan—Discomfort—Paclitaxel—lung cancer	0.00027	0.00167	CcSEcCtD
Cefotetan—Nausea—Erlotinib—lung cancer	0.000268	0.00166	CcSEcCtD
Cefotetan—Pancytopenia—Methotrexate—lung cancer	0.000267	0.00165	CcSEcCtD
Cefotetan—Anaphylactic shock—Etoposide—lung cancer	0.000267	0.00165	CcSEcCtD
Cefotetan—Diarrhoea—Vinorelbine—lung cancer	0.000267	0.00165	CcSEcCtD
Cefotetan—Neutropenia—Methotrexate—lung cancer	0.000263	0.00163	CcSEcCtD
Cefotetan—Gastrointestinal pain—Irinotecan—lung cancer	0.000263	0.00163	CcSEcCtD
Cefotetan—Anaphylactic shock—Paclitaxel—lung cancer	0.000262	0.00162	CcSEcCtD
Cefotetan—Thrombocytopenia—Etoposide—lung cancer	0.000262	0.00162	CcSEcCtD
Cefotetan—Thrombocytopenia—Paclitaxel—lung cancer	0.000257	0.00159	CcSEcCtD
Cefotetan—Abdominal pain—Irinotecan—lung cancer	0.000254	0.00157	CcSEcCtD
Cefotetan—Body temperature increased—Irinotecan—lung cancer	0.000254	0.00157	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000254	0.00157	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000249	0.00154	CcSEcCtD
Cefotetan—Vomiting—Vinorelbine—lung cancer	0.000248	0.00153	CcSEcCtD
Cefotetan—Body temperature increased—Gemcitabine—lung cancer	0.000247	0.00153	CcSEcCtD
Cefotetan—Rash—Vinorelbine—lung cancer	0.000246	0.00152	CcSEcCtD
Cefotetan—Dermatitis—Vinorelbine—lung cancer	0.000245	0.00152	CcSEcCtD
Cefotetan—Leukopenia—Docetaxel—lung cancer	0.000244	0.00151	CcSEcCtD
Cefotetan—Eosinophilia—Doxorubicin—lung cancer	0.000241	0.00149	CcSEcCtD
Cefotetan—Hypersensitivity—Irinotecan—lung cancer	0.000237	0.00146	CcSEcCtD
Cefotetan—Convulsion—Docetaxel—lung cancer	0.000236	0.00146	CcSEcCtD
Cefotetan—Agranulocytosis—Methotrexate—lung cancer	0.000234	0.00145	CcSEcCtD
Cefotetan—Cefoperazone—ALB—lung cancer	0.000232	0.129	CrCbGaD
Cefotetan—Pancytopenia—Doxorubicin—lung cancer	0.000231	0.00143	CcSEcCtD
Cefotetan—Nausea—Vinorelbine—lung cancer	0.000231	0.00143	CcSEcCtD
Cefotetan—Body temperature increased—Cisplatin—lung cancer	0.000231	0.00143	CcSEcCtD
Cefotetan—Neutropenia—Doxorubicin—lung cancer	0.000228	0.00141	CcSEcCtD
Cefotetan—Haemoglobin—Methotrexate—lung cancer	0.000226	0.0014	CcSEcCtD
Cefotetan—Haemorrhage—Methotrexate—lung cancer	0.000225	0.00139	CcSEcCtD
Cefotetan—Anaphylactic shock—Docetaxel—lung cancer	0.000222	0.00137	CcSEcCtD
Cefotetan—Pruritus—Gemcitabine—lung cancer	0.000221	0.00137	CcSEcCtD
Cefotetan—Diarrhoea—Irinotecan—lung cancer	0.00022	0.00136	CcSEcCtD
Cefotetan—Gastrointestinal pain—Etoposide—lung cancer	0.000218	0.00135	CcSEcCtD
Cefotetan—Thrombocytopenia—Docetaxel—lung cancer	0.000217	0.00135	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000215	0.00133	CcSEcCtD
Cefotetan—Hypersensitivity—Cisplatin—lung cancer	0.000215	0.00133	CcSEcCtD
Cefotetan—Gastrointestinal pain—Paclitaxel—lung cancer	0.000214	0.00133	CcSEcCtD
Cefotetan—Diarrhoea—Gemcitabine—lung cancer	0.000214	0.00133	CcSEcCtD
Cefotetan—Erythema multiforme—Methotrexate—lung cancer	0.000213	0.00132	CcSEcCtD
Cefotetan—Urticaria—Etoposide—lung cancer	0.000212	0.00131	CcSEcCtD
Cefotetan—Abdominal pain—Etoposide—lung cancer	0.000211	0.00131	CcSEcCtD
Cefotetan—Body temperature increased—Etoposide—lung cancer	0.000211	0.00131	CcSEcCtD
Cefotetan—Urticaria—Paclitaxel—lung cancer	0.000208	0.00129	CcSEcCtD
Cefotetan—Abdominal pain—Paclitaxel—lung cancer	0.000207	0.00128	CcSEcCtD
Cefotetan—Body temperature increased—Paclitaxel—lung cancer	0.000207	0.00128	CcSEcCtD
Cefotetan—Vomiting—Irinotecan—lung cancer	0.000204	0.00126	CcSEcCtD
Cefotetan—Agranulocytosis—Doxorubicin—lung cancer	0.000203	0.00126	CcSEcCtD
Cefotetan—Rash—Irinotecan—lung cancer	0.000203	0.00125	CcSEcCtD
Cefotetan—Dermatitis—Irinotecan—lung cancer	0.000202	0.00125	CcSEcCtD
Cefotetan—Diarrhoea—Cisplatin—lung cancer	0.0002	0.00124	CcSEcCtD
Cefotetan—Vomiting—Gemcitabine—lung cancer	0.000199	0.00123	CcSEcCtD
Cefotetan—Rash—Gemcitabine—lung cancer	0.000197	0.00122	CcSEcCtD
Cefotetan—Dermatitis—Gemcitabine—lung cancer	0.000197	0.00122	CcSEcCtD
Cefotetan—Hypersensitivity—Etoposide—lung cancer	0.000197	0.00122	CcSEcCtD
Cefotetan—Haemoglobin—Doxorubicin—lung cancer	0.000196	0.00121	CcSEcCtD
Cefotetan—Haemorrhage—Doxorubicin—lung cancer	0.000195	0.00121	CcSEcCtD
Cefotetan—Hypersensitivity—Paclitaxel—lung cancer	0.000193	0.00119	CcSEcCtD
Cefotetan—Cefazolin—ALB—lung cancer	0.000191	0.106	CrCbGaD
Cefotetan—Nausea—Irinotecan—lung cancer	0.000191	0.00118	CcSEcCtD
Cefotetan—Pruritus—Etoposide—lung cancer	0.000189	0.00117	CcSEcCtD
Cefotetan—Nausea—Gemcitabine—lung cancer	0.000186	0.00115	CcSEcCtD
Cefotetan—Vomiting—Cisplatin—lung cancer	0.000185	0.00115	CcSEcCtD
Cefotetan—Pruritus—Paclitaxel—lung cancer	0.000185	0.00115	CcSEcCtD
Cefotetan—Erythema multiforme—Doxorubicin—lung cancer	0.000184	0.00114	CcSEcCtD
Cefotetan—Rash—Cisplatin—lung cancer	0.000184	0.00114	CcSEcCtD
Cefotetan—Dermatitis—Cisplatin—lung cancer	0.000184	0.00114	CcSEcCtD
Cefotetan—Diarrhoea—Etoposide—lung cancer	0.000183	0.00113	CcSEcCtD
Cefotetan—Gastrointestinal pain—Docetaxel—lung cancer	0.000182	0.00112	CcSEcCtD
Cefotetan—Ceftriaxone—ALB—lung cancer	0.000181	0.101	CrCbGaD
Cefotetan—Diarrhoea—Paclitaxel—lung cancer	0.000179	0.00111	CcSEcCtD
Cefotetan—Abdominal pain—Docetaxel—lung cancer	0.000176	0.00109	CcSEcCtD
Cefotetan—Body temperature increased—Docetaxel—lung cancer	0.000176	0.00109	CcSEcCtD
Cefotetan—Leukopenia—Methotrexate—lung cancer	0.000176	0.00109	CcSEcCtD
Cefotetan—Nausea—Cisplatin—lung cancer	0.000173	0.00107	CcSEcCtD
Cefotetan—Convulsion—Methotrexate—lung cancer	0.00017	0.00105	CcSEcCtD
Cefotetan—Vomiting—Etoposide—lung cancer	0.00017	0.00105	CcSEcCtD
Cefotetan—Rash—Etoposide—lung cancer	0.000168	0.00104	CcSEcCtD
Cefotetan—Dermatitis—Etoposide—lung cancer	0.000168	0.00104	CcSEcCtD
Cefotetan—Vomiting—Paclitaxel—lung cancer	0.000167	0.00103	CcSEcCtD
Cefotetan—Rash—Paclitaxel—lung cancer	0.000165	0.00102	CcSEcCtD
Cefotetan—Dermatitis—Paclitaxel—lung cancer	0.000165	0.00102	CcSEcCtD
Cefotetan—Discomfort—Methotrexate—lung cancer	0.000165	0.00102	CcSEcCtD
Cefotetan—Hypersensitivity—Docetaxel—lung cancer	0.000164	0.00101	CcSEcCtD
Cefotetan—Anaphylactic shock—Methotrexate—lung cancer	0.00016	0.000991	CcSEcCtD
Cefotetan—Nausea—Etoposide—lung cancer	0.000159	0.000982	CcSEcCtD
Cefotetan—Pruritus—Docetaxel—lung cancer	0.000157	0.000972	CcSEcCtD
Cefotetan—Thrombocytopenia—Methotrexate—lung cancer	0.000157	0.00097	CcSEcCtD
Cefotetan—Nausea—Paclitaxel—lung cancer	0.000156	0.000963	CcSEcCtD
Cefotetan—Leukopenia—Doxorubicin—lung cancer	0.000152	0.000941	CcSEcCtD
Cefotetan—Diarrhoea—Docetaxel—lung cancer	0.000152	0.00094	CcSEcCtD
Cefotetan—Convulsion—Doxorubicin—lung cancer	0.000147	0.000911	CcSEcCtD
Cefotetan—Discomfort—Doxorubicin—lung cancer	0.000143	0.000884	CcSEcCtD
Cefotetan—Vomiting—Docetaxel—lung cancer	0.000141	0.000874	CcSEcCtD
Cefotetan—Rash—Docetaxel—lung cancer	0.00014	0.000867	CcSEcCtD
Cefotetan—Dermatitis—Docetaxel—lung cancer	0.00014	0.000866	CcSEcCtD
Cefotetan—Anaphylactic shock—Doxorubicin—lung cancer	0.000139	0.000858	CcSEcCtD
Cefotetan—Thrombocytopenia—Doxorubicin—lung cancer	0.000136	0.00084	CcSEcCtD
Cefotetan—Nausea—Docetaxel—lung cancer	0.000132	0.000816	CcSEcCtD
Cefotetan—Gastrointestinal pain—Methotrexate—lung cancer	0.000131	0.00081	CcSEcCtD
Cefotetan—Urticaria—Methotrexate—lung cancer	0.000127	0.000787	CcSEcCtD
Cefotetan—Body temperature increased—Methotrexate—lung cancer	0.000127	0.000783	CcSEcCtD
Cefotetan—Abdominal pain—Methotrexate—lung cancer	0.000127	0.000783	CcSEcCtD
Cefotetan—Hypersensitivity—Methotrexate—lung cancer	0.000118	0.00073	CcSEcCtD
Cefotetan—Gastrointestinal pain—Doxorubicin—lung cancer	0.000113	0.000701	CcSEcCtD
Cefotetan—Pruritus—Methotrexate—lung cancer	0.000113	0.000701	CcSEcCtD
Cefotetan—Urticaria—Doxorubicin—lung cancer	0.00011	0.000681	CcSEcCtD
Cefotetan—Abdominal pain—Doxorubicin—lung cancer	0.00011	0.000678	CcSEcCtD
Cefotetan—Body temperature increased—Doxorubicin—lung cancer	0.00011	0.000678	CcSEcCtD
Cefotetan—Diarrhoea—Methotrexate—lung cancer	0.00011	0.000678	CcSEcCtD
Cefotetan—Hypersensitivity—Doxorubicin—lung cancer	0.000102	0.000632	CcSEcCtD
Cefotetan—Vomiting—Methotrexate—lung cancer	0.000102	0.00063	CcSEcCtD
Cefotetan—Rash—Methotrexate—lung cancer	0.000101	0.000625	CcSEcCtD
Cefotetan—Dermatitis—Methotrexate—lung cancer	0.000101	0.000624	CcSEcCtD
Cefotetan—Pruritus—Doxorubicin—lung cancer	9.81e-05	0.000607	CcSEcCtD
Cefotetan—Nausea—Methotrexate—lung cancer	9.51e-05	0.000588	CcSEcCtD
Cefotetan—Diarrhoea—Doxorubicin—lung cancer	9.48e-05	0.000587	CcSEcCtD
Cefotetan—Vomiting—Doxorubicin—lung cancer	8.81e-05	0.000545	CcSEcCtD
Cefotetan—Rash—Doxorubicin—lung cancer	8.74e-05	0.000541	CcSEcCtD
Cefotetan—Dermatitis—Doxorubicin—lung cancer	8.73e-05	0.00054	CcSEcCtD
Cefotetan—Nausea—Doxorubicin—lung cancer	8.23e-05	0.000509	CcSEcCtD
